Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

Akkaya, CENGİZ; Kirli, SELÇUK; EKER, SALİH; Cangur, Sengul; Canbazoglu, Mustafa; Sarandol, ASLI

doi:10.1080/10177833.2010.11790673

Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

Akkaya C., Kirli S., EKER S. S., Cangur S., Canbazoglu M., Sarandol A.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.20, no.4, pp.274-287, 2010 (SCI-Expanded, Scopus, TRDizin)

Publication Type: Article / Article
Volume: 20 Issue: 4
Publication Date: 2010
Doi Number: 10.1080/10177833.2010.11790673
Journal Name: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Page Numbers: pp.274-287
Bursa Uludag University Affiliated: Yes

Abstract

Objective: This paper aims to compare the efficacy and safety of three widely used antidepressants, sertraline, reboxetine, a sertraline-reboxetine combination and venlafaxine, in the treatment of MDD and their effect on depressive symptoms in MDD patients.